• Citer

Gefitinib monotherapy in advanced nonsmall cell lung cancer: a large Western community implementation study.

par van Puijenbroek, R;Bosquée, Lionel;Meert, Anne-Pascale ;Schallier, Dominique ;Goeminne, Jean Charles;Tits, G;Collard, P;Nackaerts, Kristiaan;Canon, Jean-Luc;Duplaquet, F;Galdermans, D;Germonpré, Peter;Azerad, Marie-Agnès ;Vandenhoven, Guy;De Greve, Jacques;Vansteenkiste, Johan
Référence The European respiratory journal, 29, 1, page (128-133)
Publication Publié, 2007-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Gefitinib monotherapy in advanced nonsmall cell lung cancer: a large Western community implementation study.
Auteur:	van Puijenbroek, R; Bosquée, Lionel; Meert, Anne-Pascale; Schallier, Dominique; Goeminne, Jean Charles; Tits, G; Collard, P; Nackaerts, Kristiaan; Canon, Jean-Luc; Duplaquet, F; Galdermans, D; Germonpré, Peter; Azerad, Marie-Agnès; Vandenhoven, Guy; De Greve, Jacques; Vansteenkiste, Johan
Informations sur la publication:	The European respiratory journal, 29, 1, page (128-133)
Statut de publication:	Publié, 2007-01
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Community implementation study
	Epidermal growth factor
	Expanded access gefinitib
	Nonsmall cell lung cancer
	Treatment outcome
MeSH keywords:	Adult
	Aged
	Aged, 80 and over
	Antineoplastic Agents -- therapeutic use
	Belgium
	Carcinoma, Non-Small-Cell Lung -- drug therapy -- mortality -- pathology
	Cohort Studies
	Female
	Humans
	Lung Neoplasms -- drug therapy -- mortality -- pathology
	Male
	Middle Aged
	Quinazolines -- therapeutic use
	Retrospective Studies
	Survival Rate
	Treatment Outcome
Note générale:	Journal Article
Langue:	Anglais
Identificateurs:	urn:issn:0903-1936
	info:doi/10.1183/09031936.00050706
	info:pii/09031936.00050706
	info:scp/33846260788
	info:pmid/17005582